🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

83 results for “Pasteur” Clear

  1. Inactivated Poliomyelitis vaccine (IMOVAX)

    Sanofi Pasteur

    Poliomyelitis

    phase 2 mab completed

    1 trial

  2. Inactivated types 1, 2, and 3 poliovirus, D antigens

    Sanofi Pasteur

    Poliomyelitis

    phase 2 mab completed

    1 trial

  3. Iniparib

    Sanofi Pasteur

    Breast Cancer, Metastatic

    phase 2 small molecule completed

    1 trial

  4. Isatuximab

    Sanofi Pasteur

    Relapsed/Refractory Multiple Myeloma

    phase 2 small molecule active

    1 trial

  5. Leflunomide

    Sanofi Pasteur

    Systemic Lupus Eythematosus (SLE)

    phase 2 small molecule completed

    1 trial

  6. Live attenuated Japanese encephalitis virus; Yellow fever virus

    Sanofi Pasteur

    Japanese Encephalitis

    phase 2 mab completed

    1 trial

  7. Lunsekimig

    Sanofi Pasteur

    Asthma

    phase 2 small molecule active

    1 trial

  8. Oxaliplatin

    Sanofi Pasteur

    Uterine Neoplasms

    phase 2 small molecule terminated

    1 trial

  9. Purified Vero Rabies Vaccine Serum Free (VRVg)

    Sanofi Pasteur

    Rabies

    phase 2 mab completed

    1 trial

  10. SAR440340

    Sanofi Pasteur

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule completed

    1 trial

  11. SAR441566

    Sanofi Pasteur

    Crohn's Disease

    phase 2 small molecule active

    1 trial

  12. SAR442970

    Sanofi Pasteur

    Hidradenitis Suppurativa

    phase 2 small molecule completed

    1 trial

  13. SAR443122

    Sanofi Pasteur

    Colitis Ulcerative

    phase 2 small molecule active

    1 trial

  14. SAR447537

    Sanofi Pasteur

    Alpha 1-Antitrypsin Deficiency

    phase 2 small molecule active

    1 trial

  15. THOR-707

    Sanofi Pasteur

    Malignant Melanoma

    phase 2 small molecule terminated

    1 trial

  16. THOR-707

    Sanofi Pasteur

    Metastasis

    phase 2 small molecule terminated

    1 trial

  17. docetaxel

    Sanofi Pasteur

    Nasopharyngeal Neoplasms

    phase 2 small molecule completed

    1 trial

  18. SAR448501

    Sanofi Pasteur

    B-cell Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  19. ombrabulin (AVE8062)

    Sanofi Pasteur

    Neoplasms, Malignant

    phase 1 small molecule completed

    1 trial

  20. sarilumab SAR153191 (REGN88)

    Sanofi Pasteur

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial

  21. Bacillus Clausii Multi ATB Resist

    Sanofi Pasteur

    Diarrhea, Infantile

    approved small molecule completed

    1 trial

  22. Dupilumab

    Sanofi Pasteur

    Asthma

    approved small molecule active

    2 trials

  23. Enoxaparin

    Sanofi Pasteur

    Acute Illness

    approved small molecule completed

    1 trial

  24. Fexofenadine

    Sanofi Pasteur

    Rhinitis, Allergic, Perennial

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources